UK Study To Infect Volunteers With COVID To Speed Vaccine Development

The UK is conducting a human challenge trial to test COVID-19 vaccines by deliberately infecting volunteers. This trial, led by Imperial College London, involves 90 healthy participants aged 18-30. Volunteers will be isolated in a biosecure facility and monitored by medical professionals. The UK government is funding this potentially groundbreaking research, which could yield faster results than conventional trials. Despite ethical concerns, proponents argue the trial is necessary to accelerate vaccine development and understand the virus better. The study aims to compare vaccines directly to determine their effectiveness.

What is the primary goal of the human challenge trial being conducted in the UK?

• To develop a new vaccine

• To find a cure for COVID-19

• To study the long-term effects of COVID-19

• To test the effectiveness of vaccines against COVID-19

Why do volunteers like Courtney Harmston feel safe participating in the trial?

• They are not exposed to the virus

• They are given a special vaccine

• They are monitored by doctors in a biosecure facility

• They are isolated at home

What financial support do volunteers receive for participating in the trial?

• They receive a salary

• They are financially reimbursed for their time

• They get free healthcare

• They receive a government grant

What is one of the main ethical concerns regarding the human challenge trial?

• The limited number of participants

• The lack of a cure for COVID-19

• The high cost of the trial

• The long duration of the trial

How does the human challenge trial potentially benefit vaccine development?

• By eliminating the need for animal testing

• By increasing the number of available vaccines

• By reducing the cost of vaccine production

• By providing faster results than conventional trials